Skip to content
26-28 January, 2021
Digital Event
Menu
Home
About
About Event
Content Library
Digital FAQs
Interactive Virtual Experience
What’s On
Full Event Guide
Speakers
Agenda
Day One
Day Two
Workshop Day
Partnership
Partnership Opportunities
Partners
Get involved
Register
Pricing
Contact us
TOL2 and TOL3: Antigen Specific Tolerogenic Therapies for the Treatment of Myasthenia Gravis and ANCA vasculitis
Time:
1:30 pm
day:
Day Two
Speakers:
Charlotte Fribert
Read more
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
